![Karl Hård](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Hård
Investor Relations Contact chez
EGETIS THERAPEUTICS AB
Fortune : 99 420 $ au 31/05/2026
Profil
Karl J.
Hård is currently VP-Investor Relations & Business Development at Egetis Therapeutics AB since 2022.
Former positions include Investor Relations Contact at AstraZeneca PLC, Assistant Professor at the University of Leiden, Head-Investor Relations & Corporate Communications at Redx Pharma Plc from 2016 to 2017, and Head-Investor Relations & Communications at Kiadis Pharma NV from 2017 to 2018.
Education includes a doctorate from the University of Utrecht and graduate studies at the University of Helsinki.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB 0,03 % | 31/12/2025 | 150 982 ( 0,03 % ) | 99 420 $ | 31/05/2026 |
Postes actifs de Karl Hård
| Sociétés | Poste | Début |
|---|---|---|
| EGETIS THERAPEUTICS AB | Investor Relations Contact | 01/02/2022 |
Anciens postes connus de Karl Hård
| Sociétés | Poste | Fin |
|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 31/12/2018 |
| REDX PHARMA LTD | Investor Relations Contact | 02/07/2017 |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Public Communications Contact | - |
Formation de Karl Hård
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
13
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Leiden
University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Helsinki
 University of Helsinki Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egetis Therapeutics AB
 Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Redx Pharma Plc
 Redx Pharma Plc Pharmaceuticals: MajorHealth Technology Discovers and develops novel, small molecule & targeted therapeutics for treatment of cancer and fibrotic disease | Health Technology |
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company focused on research, development and commercialization of cell based immunotherapy products | Health Technology |
